Search clinical trials for: Nivolumab (.5 mg/kg)
Total 2019 results
-
Sameem M. Abedin, MDRecruitingGraft-versus-host DiseaseUnited States
-
MedImmune LLCCompleted
-
MedImmune LLCCompleted
-
Ullevaal University HospitalUniversity of OsloCompleted
-
Serum Institute of India Pvt. Ltd.PPDCompleted
-
Fondazione Policlinico Universitario Agostino Gemelli...CompletedProstate Cancer | Neuromuscular BlockadeItaly
-
Sidney Kimmel Comprehensive Cancer Center at Johns...RecruitingNon-Small Cell Lung CancerUnited States
-
aTyr Pharma, Inc.Foundation for Sarcoidosis ResearchCompletedPulmonary SarcoidosisUnited States
-
Flame BiosciencesWithdrawnGastric Cancer | Solid Tumor | Pancreas Cancer
-
MedImmune LLCTerminatedModerate AsthmaUnited Kingdom
-
Ludwig Institute for Cancer ResearchDaiichi Sankyo Co., Ltd.; Austin HealthCompletedMalignant Solid Tumor | Metastatic EphA2 Positive CancerAustralia
-
BioMarin PharmaceuticalTerminatedDuchenne Muscular DystrophyNetherlands, Belgium, Italy, Sweden
-
GPCR Therapeutics, Inc.CompletedMultiple Myeloma | Hodgkin Disease | Non-Hodgkin LymphomaTaiwan
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedNon-Small Cell Lung Cancer (NSCLC)United States, Canada, France, Singapore, Taiwan
-
ShaperonRecruiting
-
AM-PharmaCompleted
-
EMD SeronoMerck KGaA, Darmstadt, GermanyTerminated
-
Bausch Health Americas, Inc.CompletedRheumatoid ArthritisUnited States
-
GlaxoSmithKlineCompletedMuscular DystrophiesUnited States
-
ReAlta Life Sciences, Inc.WithdrawnCOVID-19 | Acute Lung Injury | ALIUnited States
-
Poitiers University HospitalCompleted
-
RemeGen Co., Ltd.Completed
-
Regado Biosciences, Inc.CompletedHealthy VolunteerUnited States
-
Omeros CorporationRecruitingParoxysmal Nocturnal HemoglobinuriaGermany, Greece, Switzerland, United Kingdom
-
Professor Robert SuttonMerck Sharp & Dohme LLC; Medical Research Council; Liverpool University Hospitals... and other collaboratorsRecruitingAcute PancreatitisUnited Kingdom
-
Alexion PharmaceuticalsTerminatedAcute Graft-Versus-Host Disease | GIGVHDUnited States, France
-
Centocor Research & Development, Inc.CompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous
-
QED Therapeutics, Inc.RecruitingAchondroplasiaUnited States, Spain, United Kingdom, France, Canada, Australia
-
Aridis Pharmaceuticals, Inc.Completed
-
Genor Biopharma Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Alopexx Pharmaceuticals, LLCTerminatedNeisseria GonorrhoeaeUnited States
-
CelltrionTerminatedInfluenza AKorea, Republic of
-
Acceleron Pharma Inc. (a wholly owned subsidiary...Terminated
-
Emergent BioSolutionsNational Institutes of Health (NIH)CompletedAnthraxUnited States
-
Alexion PharmaceuticalsCompletedLysosomal Acid Lipase Deficiency | Cholesterol Ester Storage Disease(CESD) | LAL-DeficiencyFrance, United States, United Kingdom, Czechia
-
Programme National de Lutte contre l'Onchocercose...CompletedOnchocerciasis, Ocular | LoiasisCongo
-
Janssen Research & Development, LLCCompleted
-
University of California, DavisMars, Inc.CompletedHealthyUnited States
-
Bio Sidus SACompleted
-
University of ReadingCompletedVasodilationUnited Kingdom
-
AO GENERIUMRecruitingMetabolic Diseases | Mucopolysaccharidosis Type IIRussian Federation
-
Janssen-Cilag International NVCompleted
-
Tunitas Therapeutics, Inc.Tunitas Therapeutics Australia Pty LtdTerminatedAllergy and ImmunologyAustralia
-
PfizerCompleted
-
Viridian Therapeutics, Inc.Not yet recruitingThyroid Eye DiseaseUnited States
-
Hoffmann-La RocheCompletedColorectal CancerFrance, Israel, Italy, Spain, Sweden, Hong Kong, Australia, Canada, Switzerland, United States, Ireland, Denmark, Germany, Taiwan, Russian Federation, China, New Zealand, Austria, United Kingdom, Hungary, Thailand, South Africa, Mexico and more
-
Rockefeller UniversityBrigham and Women's Hospital; Weill Medical College of Cornell University; University...CompletedHealthy | HIVUnited States, Germany
-
Jazz PharmaceuticalsCompletedEpilepsy | Dravet SyndromeUnited States, United Kingdom
-
Centocor, Inc.Completed